Skip to content
Screener

BioSig Technologies, Inc. STEX Q2 2026 earnings

Reported August 14, 2026 · After market close

Revenue$300.0KIn line
EPS-$0.08Miss by $0.06
Revenue estimate$300.0K
EPS estimate-$0.02

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$300.0K
EPS estimate-$0.03

Financials

Q2 2026

Income statement

See full
Revenue$146.0K—
Operating income-$15.2M+25.6%
Net income-$14.6M+28.6%
EPS (diluted)-$0.08+89.2%

Balance sheet

See full
Cash & equivalents$5.6M+98.8%
Total debt$800.0K+5,233%
Total equity$145.6M+4,126%
Total assets$159.6M+45.4%

Cash flow

See full
Operating cash flow-$11.7M-819%

Valuation & ratios

Valuation

as of 08/27/26
See full
Market cap$90.06M-46.6%
Enterprise value$85.26M-48.6%
P/S523.6×—

Returns & leverage

See full
Debt / equity0×—
Current ratio20.2×+20.2×

Segments

By segment

See full
Corporate-$146.0K—

Versus estimates

Revenue

Q2 2026$300.0KIn line

Diluted EPS

Q2 2026-$0.08Miss by $0.06
Q1 2026-$0.27Miss by $0.22Q4 2025-$0.03In lineQ3 2025-$0.47Miss by $0.44Q1 2025-$0.14Miss by $0.09Q1 2025-$0.14

FAQ

When did BioSig Technologies, Inc. report Q2 2026 earnings?
BioSig Technologies, Inc. (STEX) reported Q2 2026 earnings on August 14, 2026 after market close.
What were BioSig Technologies, Inc.'s Q2 2026 revenue and EPS?
BioSig Technologies, Inc. reported revenue of $300.0K and eps of $-0.08 for Q2 2026.
Did BioSig Technologies, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $300.0K by -. EPS missed the consensus estimate of $-0.02 by $0.06.
Where can I find BioSig Technologies, Inc.'s Q2 2026 SEC filings?
You can read the 10-Q periodic report (0001493152-26-038293) directly on SEC EDGAR. The filing index links above go to sec.gov.